Synapse: Law for Life Sciences

 

 

 

 

Welcome to Synapse - connecting you with news and analysis on legal and commercial issues in the life sciences.

Real estate toolkit
Women in IP: Economic aspects of the Unified Patent Court
Subscribe to Synapse
Unified Patent Court

Abusive denigration in the pharmaceutical industry

 

Richard Craig explores the new concept of "abusive denigration" in the context of competition law principles applicable to dominant companies and the implications it may carry.

 

 

arrowView our previous articles

Topical Issues

 

Medical devices and 3D printing - update...

Paul England analyses the potential risks posed by new 3D printing technology to rightsholders in the medical devices sector and solutions offered by the (yet to be adopted) Medical Devices Regulation...read more

 

Largest damages award on cross-undertaking upheld on appeal...

Paul England discusses the Court of Appeal decision in AstraZeneca v KRKA upholding the largest award ever made by the Patents Court as a result of the discharge of a preliminary injunction...read more

Subscribe to Synapse

Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...
Register here